Note 4 - Equity	3 Months Ended
Sep. 30, 2017
Notes
Note 4 - Equity	NOTE 4 - EQUITY *Authorized Stock* The Company’s Articles of Incorporation authorize 75,000,000 shares of common stock with a par value of $0.001 per share. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the Company is sought. *Common Shares* On August 11, 2017, the Company completed a private placement sale of 140,127 shares of its common stock. In fiscal year 2017, the Company issued 140,127 shares of its common stock in connection with the Ingredion transaction (Note 1). The Company effectively had 25,643,580 and 25,503,453 common shares issued and outstanding as of September 30, 2017 and June 30, 2017, respectively. The Company currently has no warrants outstanding. *Preferred shares* No preferred shares have been authorized or issued. *Stock Options* The Company has no outstanding stock options and does not have any outstanding rights to acquire securities.

Note 4 - Equity

3 Months Ended

Sep. 30, 2017

NOTE 4 - EQUITY

Authorized Stock

The Company’s Articles of Incorporation authorize 75,000,000 shares of common stock with a par value of $0.001 per share. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the Company is sought.

Common Shares

On August 11, 2017, the Company completed a private placement sale of 140,127 shares of its common stock. In fiscal year 2017, the Company issued 140,127 shares of its common stock in connection with the Ingredion transaction (Note 1). The Company effectively had 25,643,580 and 25,503,453 common shares issued and outstanding as of September 30, 2017 and June 30, 2017, respectively. The Company currently has no warrants outstanding.

Preferred shares

No preferred shares have been authorized or issued.

Stock Options

The Company has no outstanding stock options and does not have any outstanding rights to acquire securities.

SweeGen, Inc. 10-Q/A